Northwestern Mutual Wealth Management Co. Has $156,000 Position in Hologic, Inc. (HOLX)

Northwestern Mutual Wealth Management Co. trimmed its stake in shares of Hologic, Inc. (NASDAQ:HOLX) by 38.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,440 shares of the medical equipment provider’s stock after selling 2,156 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Hologic were worth $156,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Capital Fund Management S.A. grew its holdings in Hologic by 1,403.1% during the second quarter. Capital Fund Management S.A. now owns 102,165 shares of the medical equipment provider’s stock worth $4,636,000 after acquiring an additional 95,368 shares during the period. Martingale Asset Management L P grew its holdings in Hologic by 31.3% during the second quarter. Martingale Asset Management L P now owns 395,895 shares of the medical equipment provider’s stock worth $17,966,000 after acquiring an additional 94,365 shares during the period. Alliancebernstein L.P. grew its holdings in Hologic by 46.5% during the second quarter. Alliancebernstein L.P. now owns 1,691,191 shares of the medical equipment provider’s stock worth $76,746,000 after acquiring an additional 536,584 shares during the period. Aberdeen Asset Management PLC UK grew its holdings in Hologic by 135.9% during the second quarter. Aberdeen Asset Management PLC UK now owns 408,712 shares of the medical equipment provider’s stock worth $18,548,000 after acquiring an additional 235,425 shares during the period. Finally, HPM Partners LLC grew its holdings in Hologic by 157.6% during the second quarter. HPM Partners LLC now owns 25,974 shares of the medical equipment provider’s stock worth $2,101,000 after acquiring an additional 15,891 shares during the period. 96.38% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Northwestern Mutual Wealth Management Co. Has $156,000 Position in Hologic, Inc. (HOLX)” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/09/21/northwestern-mutual-wealth-management-co-has-156000-position-in-hologic-inc-holx.html.

In related news, Director Lawrence M. Levy sold 7,139 shares of the company’s stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $39.04, for a total value of $278,706.56. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Elaine Ullian sold 8,849 shares of the company’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $45.28, for a total value of $400,682.72. Following the completion of the sale, the director now owns 23,810 shares in the company, valued at approximately $1,078,116.80. The disclosure for this sale can be found here. In the last 90 days, insiders sold 27,594 shares of company stock worth $1,168,871. Insiders own 0.79% of the company’s stock.

Hologic, Inc. (HOLX) opened at 37.38 on Thursday. Hologic, Inc. has a 52-week low of $35.15 and a 52-week high of $46.80. The stock has a 50 day moving average price of $38.51 and a 200 day moving average price of $42.54. The stock has a market cap of $10.48 billion, a P/E ratio of 13.92 and a beta of 0.92.

Hologic (NASDAQ:HOLX) last released its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.01. The business had revenue of $806.10 million for the quarter, compared to analysts’ expectations of $799.70 million. Hologic had a return on equity of 23.18% and a net margin of 25.65%. The company’s revenue was up 12.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.51 EPS. On average, equities research analysts forecast that Hologic, Inc. will post $2.01 EPS for the current year.

Several analysts recently commented on the company. BidaskClub lowered Hologic from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Barclays PLC reaffirmed an “equal weight” rating and set a $51.00 target price (down from $53.00) on shares of Hologic in a report on Wednesday, August 9th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $45.00 target price (down from $50.00) on shares of Hologic in a report on Wednesday, August 9th. Zacks Investment Research raised Hologic from a “sell” rating to a “hold” rating in a report on Friday, August 4th. Finally, Deutsche Bank AG dropped their target price on Hologic from $51.00 to $49.00 and set a “buy” rating on the stock in a report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $48.64.

Hologic Profile

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply